• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - medications
Tag:

medications

Health

Patients taking weight-loss drugs often make 5 critical mistakes, doctor warns

by Chief Editor April 28, 2026
written by Chief Editor

Beyond the Scale: The New Era of GLP-1 Medications

For years, the conversation around GLP-1 drugs—such as semaglutide and tirzepatide—has been dominated by a single metric: the number on the scale. While their ability to manage type 2 diabetes and facilitate weight loss is well-documented, we are entering a new phase of understanding. The focus is shifting from simple weight reduction to a more comprehensive approach to systemic health.

Emerging evidence suggests these medications may offer benefits that extend far beyond appetite suppression. Experts are seeing a ripple effect of health improvements that could redefine how we treat chronic metabolic conditions.

A Shift Toward Systemic Health

The future of GLP-1 therapy isn’t just about shedding pounds; it’s about organ protection and cognitive longevity. Dr. Meena T. Malhotra, a functional medicine doctor and weight-loss specialist, has observed that patients—particularly those with severe diabetes—show improvements in areas previously unrelated to primary weight loss goals.

A Shift Toward Systemic Health
Malhotra Muscle Preservation Movement As

These benefits include enhanced heart health, better circulation, and improved liver and kidney function. Perhaps most intriguing is the potential impact on brain health and memory, suggesting that these drugs may help “rewire” the body’s defense against various diseases rather than just controlling blood sugar.

Did you know? GLP-1 medications work by improving insulin signaling, reducing appetite, and slowing gastric emptying. This multi-pronged approach is what allows them to impact various organ systems beyond the digestive tract.

The “Muscle Preservation” Movement

As these medications become more mainstream, a critical trend is emerging: the fight against “lean mass loss.” One of the most significant risks of rapid weight loss is that the body may burn muscle instead of fat. If a patient loses lean mass, they aren’t necessarily getting healthier; they may actually be compromising their metabolic rate.

View this post on Instagram about Muscle Preservation, Pro Tip
From Instagram — related to Muscle Preservation, Pro Tip

The next generation of GLP-1 users is moving toward a “protein-first” philosophy. To maintain muscle and support overall health, medical experts suggest a daily protein intake of approximately 0.5 to 0.8 grams per pound of body weight. For a 200-pound individual, So targeting 100 to 160 grams of protein daily.

Pro Tip: To prevent muscle wasting, pair your medication with consistent strength training and a diet rich in whole, minimally processed foods. Prioritizing fiber and protein helps maintain satiety and supports gut health.

The Danger of the Digital Shortcut

The rise of telehealth and online pharmacies has made GLP-1s more accessible, but it has also created a dangerous trend of “unsupervised dosing.” Many users are obtaining these medications via simple online forms without a physical exam or comprehensive blood work.

Medical professionals warn that this lack of oversight is a recipe for disaster. Underlying issues—such as thyroid dysfunction or heart conditions—must be addressed before starting these drugs to ensure the metabolism is functioning correctly. Without monthly monitoring, patients risk losing muscle mass or missing critical changes in their health markers.

the desire for “instant gratification” often leads users to increase their doses too quickly. Dr. Malhotra warns that rushing the process can lead to severe complications, including pancreatitis. The trend is shifting toward a more patient, gradual titration—typically increasing doses month by month—to allow the body to adapt.

Managing the “GLP-1 Side Effect” Profile

As the user base grows, so does the knowledge on how to mitigate common gastrointestinal issues. The future of treatment involves “lifestyle hacks” to create the medication more tolerable, reducing the likelihood of patients stopping treatment and experiencing “yo-yo” weight fluctuations.

What happens to your body when you stop taking weight-loss drugs l GMA

Strategies for Better Tolerance:

  • Meal Sizing: Transitioning to smaller, more frequent meals—roughly the size of a fist—to avoid overwhelming the digestive system.
  • Fat Reduction: Keeping fat intake low, as GLP-1s already slow stomach emptying, and high-fat foods can exacerbate nausea.
  • Digestive Support: Using ginger for nausea and incorporating fiber-rich foods like prunes, as well as liquids like broths and shakes, to prevent constipation.

Frequently Asked Questions

Can I take GLP-1s without a doctor’s supervision?

It is highly discouraged. Proper medical oversight, including blood work and physical exams, is essential to identify underlying conditions and monitor for lean muscle loss or serious side effects like pancreatitis.

How much protein do I actually need while on these drugs?

Generally, 0.5 to 0.8 grams of protein per pound of body weight is recommended to preserve lean muscle mass. Active individuals may require even more depending on workout intensity.

What should I do if I don’t see results after the first dose?

Be patient. Increasing the dose too quickly can lead to severe side effects. Most providers recommend waiting at least a month before adjusting the dosage if a plateau is reached.

Join the Conversation on Metabolic Health

Are you prioritizing protein and strength training alongside your health journey? Have you found a specific “lifestyle hack” that helps with side effects? Share your experience in the comments below or subscribe to our newsletter for the latest insights into longevity and wellness.

Subscribe to Our Health Newsletter

April 28, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Increasing Drug-Resistance By Superbugs May Lead To Another Global Healthcare Crisis

by Chief Editor March 29, 2026
written by Chief Editor

The Looming Superbug Crisis: Are We Losing the Fight Against Antibiotic Resistance?

The world is facing a growing threat: superbugs. These infection-causing microbes are becoming increasingly resistant to the antibiotics designed to kill them, jeopardizing decades of medical progress. The World Health Organization (WHO) has warned that nearly one in six bacterial infections worldwide showed resistance to antibiotic treatments in 2023, a trend that’s accelerating at an alarming rate.

How Bacteria Develop Resistance: An Evolutionary Arms Race

Bacteria are remarkably adaptable organisms. Over time, they can evolve mechanisms to defend themselves against drugs, rendering those drugs ineffective. This isn’t a new phenomenon. it’s a natural process of evolution. However, the widespread use – and often overuse – of antibiotics has dramatically accelerated this process.

Consider bacteria like Bacteroides, Enterococcus, Neisseria gonorrhoeae and Staphylococcus. These species are known for producing enzymes, like Beta-lactamase, that break down the structure of common antibiotics like penicillins and cephalosporins. To combat this, scientists developed Beta-lactamase inhibitors, which are often combined with antibiotics – for example, amoxicillin with clavulanate, or ampicillin with sulbactam – to restore their effectiveness. But even these combinations are facing increasing resistance.

A Global Problem, With Regional Hotspots

While antibiotic resistance is a global issue, certain regions are particularly vulnerable. The WHO specifically highlighted South-East Asia and the Mediterranean regions as areas of concern. However, the rapid spread of microbial diseases means that resistance can emerge and disseminate across borders quickly, impacting everyone.

The Projected Human Cost: Millions of Lives at Risk

The consequences of unchecked antibiotic resistance are dire. One study suggests that antimicrobial resistance could lead to nearly 39 million deaths globally by 2050, a 68% increase over current projections. This threat is compounded by the increasing prevalence of chronic health conditions, such as heart failure, diabetes, and autoimmune diseases, which can weaken the immune system and make individuals more susceptible to infection.

Did you know? The misuse and overuse of antibiotics in humans, animals, and plants are major drivers of antimicrobial resistance.

What Can Be Done? The Importance of Antibiotic Stewardship

Addressing this crisis requires a multifaceted approach, with a central focus on improving antibiotic stewardship. This involves optimizing how antibiotics are prescribed by clinicians and how patients use them. The Centers for Disease Control and Prevention (CDC) outlines core elements of antibiotic stewardship, encompassing strategies for preventing misuse in hospitals, outpatient settings, and even at home.

Patient education is also crucial. Understanding that antibiotics are ineffective against viral infections (like the common cold or flu) and that completing the full course of prescribed antibiotics is essential – even if you feel better – can significantly slow the development of resistance.

The Pipeline Problem: A Lack of New Antibiotics

The development of new antibiotics has slowed dramatically in recent years. Here’s partly due to the economic challenges associated with antibiotic research and development. Pharmaceutical companies often prioritize developing drugs for chronic conditions, which offer a more consistent revenue stream, over antibiotics, which are typically used for short periods.

Pro Tip: Never share your antibiotics with others, and always follow your doctor’s instructions carefully.

Looking Ahead: Surveillance and Innovation

Effective surveillance of antibiotic resistance patterns is essential for tracking the spread of superbugs and informing public health interventions. The WHO emphasizes the necessitate for improved data collection and analysis to understand the evolving threat. Investment in research and development of new vaccines, diagnostics, and medicines is also critical.

FAQ: Antibiotic Resistance

Q: What is antibiotic resistance?
A: Antibiotic resistance occurs when bacteria change over time and no longer respond to drugs designed to kill them.

Q: Why is antibiotic resistance a problem?
A: It makes infections harder to treat, increases the risk of disease spread, and can lead to higher healthcare costs and mortality rates.

Q: What can I do to help prevent antibiotic resistance?
A: Use antibiotics only when prescribed by a doctor, complete the full course of treatment, and practice excellent hygiene to prevent infections.

Q: Are superbugs only a problem in hospitals?
A: No, superbugs can spread in any setting, including communities, schools, and workplaces.

This is a complex challenge with no easy solutions. However, by prioritizing antibiotic stewardship, investing in research, and raising public awareness, You can work towards slowing the spread of antibiotic resistance and protecting public health for generations to come.

Want to learn more? Explore the World Health Organization’s resources on antimicrobial resistance and the CDC’s information on antibiotic use.

March 29, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

GLP-1 meds show promise for treating addiction

by Chief Editor March 29, 2026
written by Chief Editor

Beyond Weight Loss: Could Diabetes Drugs Quiet the Roar of Addiction?

For years, GLP-1 receptor agonists like semaglutide and tirzepatide have been making headlines as revolutionary weight-loss medications. Originally developed to treat type 2 diabetes, their ability to curb appetite and promote weight loss has fueled a surge in popularity. But emerging research suggests these drugs may offer a far broader benefit: a potential breakthrough in the treatment of substance utilize disorders.

A Common Pathway to Addiction?

A recent study from Washington University School of Medicine in St. Louis, published in The BMJ, analyzed the health records of over 600,000 US veterans with type 2 diabetes. Researchers found that those taking GLP-1 medications had a 14% reduced risk of developing any substance use disorder compared to those taking other diabetes medications. The benefits extended across multiple substances, including alcohol (18% reduction), cannabis (14%), cocaine and nicotine (20%), and opioids (25%).

“In addiction medicine, a lot of treatments target just one thing,” explains senior author Ziyad Al-Aly. “But there is no medication that works across addictive substances, let alone all of them. The revelation about GLP-1 medication is that it really works against all major substances.”

Quieting the ‘Drug Noise’

The study suggests GLP-1s don’t target specific substances, but rather a common biological pathway underlying addiction – the intense craving that drives compulsive behavior. Al-Aly describes this as quieting the “drug noise,” a relentless preoccupation that fuels addiction, mirroring the “food noise” often reported by those taking the drugs for weight management.

This concept is particularly promising for substances like methamphetamine, where currently no dedicated medicinal treatments exist. The researchers theorize that GLP-1 receptors in the brain, specifically in regions modulating reward processing, may be key to reducing these cravings.

Real-World Impact and Potential Benefits

The implications of these findings are significant. With millions of Americans already using GLP-1 medications, a population-level impact on substance use disorder rates is conceivable. The potential for a dual benefit – treating both chronic conditions like diabetes or obesity and addressing underlying addiction – is a compelling prospect.

The study translated to seven fewer new substance use disorder diagnoses per 1,000 GLP-1 users. This suggests a tangible reduction in harm, potentially including fewer overdoses and deaths.

What’s Next for GLP-1s and Addiction Treatment?

While the study demonstrates a strong association, further research is needed to fully understand the mechanisms at play and to determine the optimal use of GLP-1s in addiction treatment. Clinical trials specifically designed to evaluate GLP-1s for substance use disorders are crucial.

Researchers are also exploring whether GLP-1s could be used preventatively, reducing the risk of developing addiction in individuals predisposed to substance use disorders.

Frequently Asked Questions

Q: Can GLP-1s cure addiction?
A: No, GLP-1s are not a cure for addiction. However, research suggests they can significantly reduce cravings and the risk of developing or worsening a substance use disorder.

Q: Are GLP-1s safe for everyone?
A: GLP-1s have potential side effects, and are not suitable for everyone. It’s essential to discuss the risks and benefits with a healthcare professional.

Q: Will GLP-1s replace traditional addiction treatments?
A: It’s unlikely GLP-1s will replace existing treatments. They may, however, become a valuable addition to a comprehensive addiction treatment plan.

Q: What substances have shown a response to GLP-1 treatment in this study?
A: The study showed a reduction in risk for alcohol, cannabis, cocaine, nicotine, and opioids.

Did you understand? GLP-1 receptors are found in areas of the brain that control reward processing, suggesting a direct link between these medications and the brain’s addiction pathways.

Pro Tip: If you are struggling with substance use disorder, talk to your doctor about all available treatment options, including potential benefits and risks of GLP-1 medications.

Learn more about the research at The BMJ.

Have thoughts on this emerging research? Share your comments below!

March 29, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

6 Common Medications That Don’t Mix Well with Multivitamins

by Chief Editor March 22, 2026
written by Chief Editor

The Growing Complexity of Medication and Supplement Interactions: What the Future Holds

About one-third of U.S. Adults take a daily multivitamin, often to address nutritional gaps. However, combining multivitamins with prescription and over-the-counter medications can alter how the body absorbs either the supplement or the drug, due to shared absorption pathways and competition for enzymes. As the population ages and polypharmacy – the utilize of multiple medications – becomes more common, understanding these interactions is increasingly critical.

The Rise of Personalized Supplementation

The “one-size-fits-all” approach to multivitamins is fading. Experts are increasingly emphasizing that supplementation should be personalized, based on individual needs and medication lists. This trend is fueled by advancements in nutrigenomics – the study of how genes interact with nutrients – and a growing awareness that individual responses to supplements can vary significantly.

Thyroid Medications and Absorption Challenges

Interactions between thyroid medication (levothyroxine) and multivitamins containing calcium and iron remain a significant concern. Calcium and iron can bind to levothyroxine in the digestive tract, reducing its effectiveness. Future strategies may involve developing formulations of levothyroxine that are less susceptible to these interactions, or personalized multivitamin recommendations based on individual thyroid function and medication dosages.

Blood Thinners: A Delicate Balance with Vitamin K

For individuals on warfarin, consistency in vitamin K intake is paramount. Fluctuating levels can impact the drug’s effectiveness or increase bleeding risk. The future may see more sophisticated monitoring tools to assess individual sensitivity to vitamin K and guide personalized dietary recommendations. Easy bruising, unusual bleeding, or recent leg swelling should always be reported to a healthcare provider, especially if supplement intake has changed.

Antibiotics and Mineral Competition

Certain antibiotics, like doxycycline and ciprofloxacin, can bind to minerals in multivitamins (magnesium, calcium, iron, and zinc), decreasing the antibiotic’s effectiveness. Pharmacists are playing an increasingly important role in educating patients about appropriate timing of doses to minimize these interactions. Expect to see more automated medication reminders and scheduling tools that incorporate supplement considerations.

Osteoporosis Medications: Timing is Everything

Bisphosphonates, used to treat osteoporosis, require careful timing with supplements. These medications work best on an empty stomach, and even compact amounts of calcium, iron, or other minerals can reduce their effectiveness. Future research may focus on developing bisphosphonate formulations that are less affected by dietary factors.

Diuretics and Electrolyte Management

Diuretics impact electrolyte balance, and taking multivitamins containing calcium, magnesium, and potassium can alter their absorption and metabolism. Healthcare providers are increasingly recommending electrolyte level checks before starting supplements for patients on diuretics. Wearable sensors that continuously monitor electrolyte levels could develop into more common, providing real-time data for personalized supplementation plans.

Acid-Reducing Medications and Nutrient Deficiencies

Long-term use of PPIs and antacids can reduce the absorption of vitamin B12, magnesium, and iron. Alternative strategies, such as sublingual vitamin B12 or injections, are being explored. Future formulations of these medications may incorporate nutrients to mitigate absorption issues.

The Role of Pharmacists and AI-Powered Tools

Pharmacists are becoming essential partners in medication management, reviewing supplement lists and identifying potential interactions. AI-powered tools are similarly emerging, capable of analyzing complex medication regimens and flagging potential supplement interactions. These tools can provide personalized recommendations to both patients and healthcare providers.

Pro Tip

Always inform your doctor and pharmacist about all medications and supplements you are taking, including vitamins, minerals, and herbal remedies.

Did You Know?

Drug-nutrient interactions can change how your medication works, potentially leading to reduced effectiveness or increased side effects.

FAQ

Can I take a multivitamin if I’m on medication?

Yes, but it’s crucial to consult with your doctor or pharmacist to ensure there are no potential interactions.

What is polypharmacy?

Polypharmacy is the use of multiple medications by a single person, often five or more.

Why is vitamin K important for people on blood thinners?

Vitamin K plays a role in blood clotting, and consistent intake is important for those taking warfarin to maintain stable medication effects.

The future of medication and supplement interactions lies in personalization, advanced monitoring, and collaborative care. By prioritizing open communication with healthcare professionals and embracing innovative technologies, individuals can navigate the complexities of polypharmacy and optimize their health outcomes.

March 22, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Stopping Ozempic? New study reveals surprising weight regain results after GLP-1s

by Chief Editor March 21, 2026
written by Chief Editor

The Ozempic Effect: What Happens When You Stop, and What’s Next for Weight Management?

Millions have turned to GLP-1 medications like Ozempic, Wegovy, and Zepbound for weight loss. But what happens when the injections stop? A new study from the Cleveland Clinic offers a more nuanced picture than previous research, suggesting that significant weight regain isn’t inevitable – but continued engagement with healthcare is key.

Beyond the “Rebound” Effect: Real-World Insights

Initial clinical trials raised concerns about a substantial rebound effect, with patients quickly regaining lost weight after discontinuing GLP-1s. However, the Cleveland Clinic study, analyzing data from nearly 8,000 adults, paints a different scenario. Patients experienced minimal weight regain – averaging just 0.5% after one year – particularly those who transitioned to alternative treatments.

This difference highlights the importance of considering “real-world” outcomes versus the controlled environment of clinical trials. In practice, many patients don’t simply stop treatment; they switch medications or integrate lifestyle changes.

The Power of Transition: Staying on a Path to Wellness

The study revealed that approximately 27% of patients transitioned to different obesity medications, while another 20% restarted their original medication after resolving issues like insurance coverage or side effects. A further 14% engaged in intensive lifestyle modification programs, working with dietitians and exercise specialists.

“Our real-world data show that many patients who stop semaglutide or tirzepatide restart the medication or transition to another obesity treatment, which may explain why they regain less weight than patients in randomized trials,” explained Dr. Hamlet Gasoyan, lead study author.

Surgery vs. Medication: A Long-Term Perspective

Recent findings from the Cleveland Clinic also suggest that bariatric surgery may offer more sustained weight loss benefits than GLP-1 medications in the long run. While injectable medications can be effective, surgery appears to provide more durable results.

Genetics and GLP-1s: A Personalized Approach?

Emerging research indicates that an individual’s genetic makeup could influence how well they respond to weight loss drugs. This suggests a future where treatment plans are tailored to a patient’s unique genetic profile, maximizing effectiveness and minimizing side effects.

The Future of Weight Management: Beyond the Injection

The evolving landscape of weight management points towards a more holistic and personalized approach. This includes:

  • Combination Therapies: Integrating GLP-1s with other medications and lifestyle interventions.
  • Oral Medications: The recent approval of oral Wegovy offers a needle-free alternative, potentially increasing accessibility.
  • Intensive Lifestyle Programs: Structured programs focusing on diet, exercise, and behavioral changes.
  • Genetic Testing: Utilizing genetic information to predict treatment response and personalize care.

Researchers emphasize the importance of continued engagement with the healthcare system, whether through alternative prescriptions or structured lifestyle support, to maintain weight loss success.

FAQ: GLP-1s and Weight Regain

Q: What happens if I stop taking Ozempic?
A: A recent study suggests that significant weight regain isn’t inevitable, especially if you transition to another treatment or lifestyle program.

Q: Is surgery a better option than Ozempic for long-term weight loss?
A: The Cleveland Clinic has found that surgery can lead to more sustained weight loss compared to medication.

Q: Does my genetics play a role in how well weight loss drugs work?
A: Yes, emerging research suggests that genetics can influence treatment response.

Q: What percentage of patients regain weight after stopping GLP-1s?
A: The Cleveland Clinic study showed an average regain of just 0.5% after one year, significantly less than observed in clinical trials.

Q: What can I do to prevent weight regain after stopping GLP-1 medication?
A: Transition to another medication, engage in an intensive lifestyle modification program, or continue working closely with your healthcare provider.

Source: Stopping Ozempic? New study reveals surprising weight regain results after GLP-1s

Want to learn more about managing your weight? Explore our other articles on nutrition, fitness, and healthy living. Share your experiences and questions in the comments below!

March 21, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

What really happens after coming off Ozempic and other weight-loss drugs?

by Chief Editor March 18, 2026
written by Chief Editor

The Ozempic Effect: What Happens When the Shots Stop?

Millions have turned to GLP-1 medications like Ozempic, Wegovy, and Zepbound for weight loss, but a crucial question remains: what happens when patients discontinue use? Initial concerns centered around significant weight regain, mirroring the results seen in tightly controlled clinical trials. But, emerging real-world data paints a more nuanced picture.

Beyond the Clinical Trial: Real-World Outcomes

A recent study from the Cleveland Clinic, published in the journal Diabetes, Obesity and Metabolism, analyzed data from nearly 8,000 adults in Ohio and Florida who used semaglutide or tirzepatide for three to twelve months before stopping. Unlike the rigid environments of clinical trials, this study reflected how patients navigate treatment in everyday life – often switching between medications.

The findings offer a hopeful perspective. Patients did not experience substantial weight regain in the year following discontinuation of GLP-1 medication. For those specifically treated for obesity, the average weight loss prior to stopping was 8.4%, and they only regained 0.5% on average one year later.

Why the Difference? The Role of Continued Care

Dr. Hamlet Gasoyan, lead study author, suggests the discrepancy between clinical trial results and real-world outcomes lies in continued engagement with the healthcare system. “Our real-world data show that many patients who stop semaglutide or tirzepatide restart the medication or transition to another obesity treatment, which may explain why they regain less weight than patients in randomized trials,” he stated.

This highlights a critical point: successful weight management isn’t solely about the medication itself, but about ongoing support and alternative options when a patient stops the initial treatment.

Transitioning and Adapting: What Patients Are Doing

The Cleveland Clinic study revealed that approximately 27% of patients transitioned to different medications, including older-generation obesity drugs. Another 20% eventually restarted their original medication after resolving issues like insurance coverage or side effects. 14% engaged in intensive lifestyle modification programs, working with dietitians and exercise specialists.

These findings suggest that patients are actively seeking and utilizing alternative strategies to maintain their weight loss journey, mitigating the risk of significant regain.

Limitations and Future Research

Researchers acknowledge the study’s limitations, noting that the data was drawn from a single integrated health system in Ohio and Florida. Patient characteristics and healthcare delivery models vary across the U.S., potentially impacting the generalizability of the findings.

Future research will focus on comparing the effectiveness of different treatment options for patients discontinuing semaglutide or tirzepatide, aiming to provide clinicians and patients with informed decision-making tools.

FAQ: GLP-1 Discontinuation

Q: Will I definitely regain weight if I stop Ozempic or Wegovy?
A: Not necessarily. This study suggests that many patients do not regain significant weight, particularly if they transition to another treatment or lifestyle program.

Q: What are the alternatives to GLP-1 medications?
A: Alternatives include older-generation obesity drugs, intensive lifestyle modification programs (diet and exercise), and potentially surgery.

Q: Is this study applicable to everyone?
A: The study was conducted within a specific healthcare system. Results may vary depending on individual circumstances and access to care.

Q: What should I do if I’m considering stopping a GLP-1 medication?
A: Discuss your options with your healthcare provider to develop a plan for continued weight management.

Did you know? Patients who remain engaged with the healthcare system – through alternative prescriptions or lifestyle support – are more likely to maintain their weight loss after stopping GLP-1 medications.

Explore more health stories on Fox News Digital.

Sign up for our health newsletter to stay informed about the latest medical breakthroughs and wellness tips: Click here to subscribe.

March 18, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Valerian root compared to Valium for anti-anxiety, while experts warn of risks

by Chief Editor March 8, 2026
written by Chief Editor

Nature’s Valium: Exploring the Rise of Herbal Anxiety Relief

For centuries, people have turned to nature for remedies to soothe the mind and body. Now, as anxiety rates climb and individuals seek alternatives to traditional pharmaceuticals, an ancient herb is gaining renewed attention: valerian root. Often dubbed “nature’s Valium,” valerian is being explored as a potential aid for sleep, stress and mild anxiety. But how does it stack up, and what does the future hold for herbal anxiety solutions?

A History Rooted in Tradition

Valerian’s story isn’t recent. Its use dates back to ancient Greece and Rome, with records indicating its sedative properties were recognized even then. The plant, Valeriana officinalis, grows as a flowering bush and is native to Europe and Asia. Today, it’s also found in northeastern America. Traditionally, the roots have been dried, crushed, and used in teas, tinctures, capsules, or loose powders.

How Does Valerian Work?

While the exact mechanisms aren’t fully understood, research suggests valerian impacts gamma-aminobutyric acid (GABA) receptors in the brain. GABA is a natural nerve-regulating amino acid that can promote relaxation. Some studies also indicate potential benefits for premenstrual syndrome symptoms. A 2020 review published in the Journal of Evidence-Based Integrative Medicine found that both powdered root and root extracts showed a “clear” benefit in treating anxiety.

Valerian vs. Valium: What’s the Difference?

Despite the nickname, experts caution against directly comparing valerian to diazepam (Valium). Valium, a prescription sedative, is used to treat anxiety, seizures, and muscle spasms by calming the nervous system. While both may address anxiety, valerian is considered a milder ingredient, more suitable for mild cases of anxiety and sleep issues. Valium carries a risk of dependence and potential adverse effects that are not typically associated with valerian.

The Growing Demand for Natural Alternatives

The interest in valerian reflects a broader trend: a growing desire for natural and holistic approaches to mental wellness. People are increasingly seeking alternatives to prescription medications, often due to concerns about side effects or the potential for dependence. This demand is fueling research into other herbal remedies and natural compounds with calming properties.

Future Trends in Herbal Anxiety Relief

Several trends are shaping the future of herbal anxiety relief:

  • Personalized Herbalism: Advances in genetic testing and personalized medicine may lead to tailored herbal formulations based on an individual’s unique biochemistry.
  • Combination Therapies: Combining valerian with other herbs known for their calming effects, such as chamomile, lavender, or lemon balm, could enhance efficacy.
  • Standardized Extracts: Improving the consistency and quality of valerian extracts through standardized manufacturing processes will be crucial for reliable results.
  • Focus on the Gut-Brain Connection: Research increasingly highlights the link between gut health and mental wellbeing. Herbs that support gut health, alongside those with calming properties, may become more popular.
  • Technological Integration: Apps and wearable devices could monitor stress levels and provide personalized recommendations for herbal interventions.

Beyond Valerian: Other Promising Herbs

While valerian is gaining prominence, other herbs are also being investigated for their potential to alleviate anxiety and promote relaxation. These include:

  • Ashwagandha: An adaptogen traditionally used in Ayurvedic medicine to assist the body cope with stress.
  • Rhodiola Rosea: Another adaptogen believed to improve mental performance and reduce fatigue.
  • Passionflower: Traditionally used for anxiety and insomnia.
  • Lemon Balm: Known for its calming and mood-boosting properties.

Expert Perspectives

Dr. Joseph Mercola emphasizes the importance of addressing the root causes of poor sleep and anxiety, rather than solely relying on herbal sedatives. He suggests incorporating practices like sunlight exposure, magnesium supplementation, and GABA/glycine intake to support the body’s natural relaxation mechanisms.

Frequently Asked Questions (FAQ)

Q: Is valerian root safe?
A: Valerian is generally considered safe for most people, but some may experience mild side effects like headaches or digestive upset.

Q: Can I take valerian with other medications?
A: It’s essential to consult with a healthcare professional before taking valerian, especially if you are already taking medications, as it may interact with certain drugs.

Q: How long does it take for valerian to work?
A: The effects of valerian can vary. Some people may experience benefits within a few days, while others may take several weeks to notice a difference.

Q: Is valerian root addictive?
A: No, valerian root is not considered addictive.

Did you know? The American Botanical Council plays a key role in researching and promoting the responsible use of herbal supplements like valerian.

Pro Tip: Start with a low dose of valerian and gradually increase it as needed, paying attention to how your body responds.

Ready to explore natural solutions for stress and anxiety? Share your experiences with herbal remedies in the comments below! Explore more health articles on Fox News.

March 8, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

GLP-1 drugs linked to bone fracture risk in older diabetes patients, study finds

by Chief Editor March 8, 2026
written by Chief Editor

The Shifting Landscape of GLP-1s: Bone Health and the Future of Weight Loss Drugs

GLP-1 medications like Ozempic and Wegovy have revolutionized the treatment of type 2 diabetes and obesity, but emerging research is prompting a closer look at potential side effects, particularly concerning bone health in older adults. A recent study published in the Journal of Clinical Endocrinology & Metabolism revealed an 11% higher risk of fragility fractures in those over 65 starting GLP-1s compared to those using other diabetes medications.

Why the Concern? A Deeper Dive into Bone Density

While the increased risk appears modest, experts emphasize its significance for a vulnerable population already predisposed to fractures. Both age and type 2 diabetes independently increase fracture risk, making this group particularly susceptible. The concern isn’t new, but is gaining traction as newer, more potent GLP-1s become widely prescribed.

Previous research with older GLP-1 medications didn’t show the same increased fracture risk. However, contemporary medications are different, and the patient demographic is changing.

Weight Loss and Bone Health: A Complex Relationship

The link between GLP-1s and bone health isn’t fully understood, but several factors are likely at play. Rapid weight loss, a common effect of these medications, is known to reduce bone density. This occurs because less mechanical load is placed on the skeleton. Sense of astronauts in zero gravity – without the constant stress of weight-bearing, bone density declines.

reduced calorie intake associated with weight loss can lead to lower consumption of essential nutrients like calcium, vitamin D, and protein, all crucial for maintaining bone strength. Separate research presented at the American Academy of Orthopaedic Surgeons’ annual meeting indicated a 29% higher relative risk of osteoporosis over five years in GLP-1 users compared to non-users, and slightly higher rates of gout.

Beyond Fractures: Osteoporosis and Gout on the Rise?

The emerging data suggests a potential connection between GLP-1 use and an increased risk of osteoporosis, and gout. One study found that gout affected 7.4% of GLP-1 users compared to 6.6% of non-users – a roughly 12% relative increase. Osteomalacia, a softening of the bones, was also observed at a higher rate in GLP-1 users, though this finding requires further investigation.

What Does This Mean for Patients and Physicians?

Experts are quick to emphasize that these findings shouldn’t discourage the appropriate use of GLP-1 medications. These drugs offer significant benefits for blood sugar control, weight loss, and cardiovascular risk reduction. However, a more proactive approach to monitoring bone health is warranted.

Proactive Steps for Bone Health

Before initiating GLP-1 therapy in older adults, healthcare providers should assess bone density. Alongside medication, patients should prioritize adequate nutrition, including sufficient calcium, vitamin D, and protein intake. Resistance training is also crucial for maintaining muscle mass and bone strength during weight loss.

Novo Nordisk, the manufacturer of Wegovy and Ozempic, acknowledges the importance of patient safety and continues to monitor research related to its products. The current FDA-approved labeling reflects known risks and benefits.

Future Trends and Research Directions

The conversation surrounding GLP-1s is evolving. Here’s what we can expect to observe in the coming years:

  • Personalized Medicine: Tailoring GLP-1 therapy based on individual risk factors, including bone health status.
  • Combination Therapies: Exploring the use of bone-strengthening medications alongside GLP-1s for high-risk patients.
  • Long-Term Studies: Conducting more extensive long-term studies to fully understand the impact of GLP-1s on bone health and other potential side effects.
  • New Formulations: Development of GLP-1 formulations designed to minimize potential negative effects on bone metabolism.

FAQ: GLP-1s and Bone Health

Q: Should I stop taking my GLP-1 medication if I’m concerned about my bone health?
A: No. Discuss your concerns with your doctor. They can assess your individual risk factors and determine the best course of action.

Q: What tests can be done to assess my bone health?
A: A bone density scan (DEXA scan) is the most common test used to measure bone density.

Q: Are there any lifestyle changes I can make to protect my bones while taking GLP-1s?
A: Yes. Ensure you’re getting enough calcium, vitamin D, and protein in your diet, and engage in regular weight-bearing exercise.

Q: Does this apply to all GLP-1 medications?
A: The research is ongoing, but current evidence suggests the risk may be higher with newer, more potent GLP-1s.

Did you realize? Resistance training, even simple exercises like lifting light weights or using resistance bands, can significantly improve bone density.

Stay informed about the latest developments in GLP-1 research and discuss any concerns you have with your healthcare provider. The future of weight loss medication is promising, but a cautious and informed approach is essential.

Explore more lifestyle stories on Fox News.

March 8, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Sprout Health GLP-1 Weight Loss in 2026 — Compounded Semaglutide Pricing, FDA Status, and What To Know Before Starting a Telehealth GLP-1 Program

by Chief Editor February 26, 2026
written by Chief Editor

The Shifting Landscape of GLP-1 Weight Loss: What Consumers Need to Know in 2026

The demand for GLP-1 medications like semaglutide and tirzepatide for weight loss continues to surge, but the path to accessing these treatments is becoming increasingly complex. Telehealth platforms like Sprout Health have emerged as popular options, but recent regulatory changes and a shifting market demand a closer look. This article breaks down the current state of affairs, focusing on the distinctions between FDA-approved drugs and compounded medications, and what consumers should verify before starting a telehealth program.

Understanding Compounded vs. FDA-Approved GLP-1s

It’s crucial to understand that compounded semaglutide and tirzepatide are not FDA-approved finished products. The FDA has not reviewed them for safety, effectiveness, or quality as complete formulations. These medications are prepared by licensed pharmacies based on individual prescriptions, differing significantly from branded medications like Wegovy, Ozempic, Zepbound, or Mounjaro, which have undergone rigorous clinical trials.

Pro Tip: Always confirm with your healthcare provider whether an FDA-approved option is suitable for your needs before considering a compounded medication.

The FDA’s Evolving Stance and the Semaglutide Shortage

The regulatory landscape has been in flux. The semaglutide drug shortage, which previously allowed compounding pharmacies to produce versions of the drug, has officially been resolved as of February 2026. This means the exception allowing compounding pharmacies to create essentially copies of commercially available drugs has narrowed significantly. The FDA has indicated it will prioritize enforcement against mass-marketed, non-FDA-approved GLP-1 products.

However, the FDA acknowledges a continued need for patient-specific compounding in cases where an FDA-approved drug cannot meet a patient’s unique medical needs. This distinction is key.

How Telehealth Platforms Like Sprout Health Operate

Telehealth platforms like Sprout Health act as intermediaries, connecting patients with licensed medical providers and partner compounding pharmacies. Sprout Health itself doesn’t prescribe medications or make clinical decisions. The process involves three distinct entities:

  • Sprout Health Partners LLC: Operates the technology platform, providing customer support and coordinating care.
  • Licensed Medical Providers: Independently review patient information and determine if a prescription is clinically appropriate. These clinicians operate through MD Integrations (MDI).
  • Licensed Partner Pharmacies: Compound and dispense medications based on prescriptions. Sprout Health partners with Foothills Pharmacy and Promise Pharmacy.

The platform begins with an online pre-qualification assessment, followed by a detailed medical questionnaire reviewed by a licensed clinician. If a prescription is issued, the medication is shipped to the consumer, typically within five to seven business days.

Pricing and Availability

As of early 2026, Sprout Health lists compounded semaglutide at $249 per month and compounded tirzepatide at $299 per month. The company operates on a month-to-month subscription basis and does not accept insurance. Services are currently available in most states, excluding Alabama, Arkansas, California, Louisiana, Mississippi, and North Dakota. Eligibility can change, so direct verification with the platform is recommended.

Understanding the Risks and Limitations

GLP-1 receptor agonists can have side effects, including nausea, vomiting, and diarrhea. More serious, though less common, reactions have been reported. These medications are not suitable for individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

It’s as well important to remember that a telehealth evaluation may not capture all the clinical information available during an in-person examination. Consumers with complex medical histories should consult with their primary care provider.

What to Verify Before Enrolling

Consumers should conduct thorough due diligence before enrolling in any telehealth GLP-1 program. Key areas to verify include:

  • Business Registration: Confirm the legitimacy of Sprout Health Partners LLC.
  • Clinician Licensing: Verify the credentials of the prescribing clinicians through their state medical board.
  • Pharmacy Licensing: Confirm the licensing and LegitScript certification of the partner pharmacies.
  • Terms and Policies: Carefully review the platform’s terms, refund policies, and subscription structure.
  • Regulatory Compliance: Understand how the platform’s compounding model aligns with current FDA guidance.

Comparing Access Models

In 2026, consumers have three primary options for accessing GLP-1 medications:

  • FDA-Approved Branded Medications: Accessed through traditional healthcare, offering established safety and efficacy but often at a higher cost.
  • Compounded GLP-1s via Telehealth: A potentially more affordable option, but with regulatory and quality considerations.
  • In-Person Clinical Weight Management Programs: Combining prescriptions with comprehensive clinical oversight, offering a more thorough evaluation but at a higher cost.

Important Evidence Boundaries

It’s vital to distinguish between evidence for the active ingredients (semaglutide and tirzepatide) and evidence for the compounded products themselves. Clinical trials have demonstrated the effectiveness of FDA-approved branded versions, but these results cannot be directly applied to compounded formulations, which have not undergone equivalent testing.

Frequently Asked Questions

Are compounded GLP-1 medications safe?
Compounded medications can be safe when prepared by licensed pharmacies under the direction of a licensed prescriber, but they have not undergone the same FDA review as approved drugs.
Is Sprout Health FDA-approved?
Sprout Health is a telehealth platform; the compounded medications offered through the platform are not FDA-approved as finished products.
What is the difference between semaglutide and tirzepatide?
Both are GLP-1 receptor agonists, but tirzepatide also acts on the GIP pathway, potentially leading to greater weight loss in some individuals.
Can I leverage insurance with Sprout Health?
No, Sprout Health does not accept or bill insurance.

For questions about Sprout Health GLP-1 Weight Loss, contact [email protected] or +1 (833) 496-4020.

February 26, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

“Best Peptides for Hair Growth” Search Trends Surge as Telehealth Platforms Expand FDA-Approved Medication Access in 2026

by Chief Editor January 9, 2026
written by Chief Editor

The Future of Hair Loss Treatment: Beyond Pills and Potions

The quest for a full head of hair is as old as time, but the landscape of hair loss treatment is rapidly evolving. No longer are consumers simply asking “what’s the best?” They’re dissecting formats, scrutinizing medical oversight, and demanding convenience. This shift is driving innovation, and the next few years promise a wave of personalized, tech-driven solutions.

Personalized Medicine: The Rise of Genetic Testing

One of the most significant trends is the move towards personalized medicine. Generic treatments don’t work for everyone, and understanding why is crucial. Genetic testing is becoming increasingly accessible, offering insights into individual predispositions to hair loss, responsiveness to specific medications like finasteride, and even potential side effects. Companies are beginning to offer at-home kits that analyze genes related to androgenetic alopecia, allowing for tailored treatment plans.

Did you know? Approximately 50% of men experience noticeable hair loss by age 50, but genetic factors play a significant role in determining the onset and severity.

The Topical Revolution: Beyond Minoxidil

While minoxidil remains a cornerstone of hair loss treatment, research is expanding the possibilities of topical applications. New compounds are being developed to target different pathways involved in hair follicle dysfunction. We’re seeing increased interest in topical finasteride (despite FDA cautions regarding compounded versions – see FAQ), as well as innovative ingredients like Redensyl, a combination of dihydrofolliculic acid and zinc, which aims to reactivate hair follicle stem cells. Delivery systems are also improving, with micro-needling and liposomal encapsulation enhancing absorption and efficacy.

Telehealth 2.0: AI-Powered Diagnostics and Monitoring

Telehealth platforms like PeterMD have already disrupted the traditional dermatology model, offering convenient access to prescriptions. But the future of telehealth goes beyond simple consultations. Artificial intelligence (AI) is poised to play a major role in diagnostics. AI-powered apps can analyze scalp images to assess hair density, identify patterns of hair loss, and even predict future progression. Wearable sensors are also being explored to monitor scalp health in real-time, providing data on hydration, sebum production, and inflammation.

Pro Tip: When considering telehealth options, always verify the credentials of the healthcare providers and understand the platform’s data privacy policies.

Exosomes and Regenerative Medicine: The Cutting Edge

Perhaps the most exciting – and still largely experimental – area of hair loss treatment is regenerative medicine. Exosomes, tiny vesicles secreted by cells, are gaining attention for their ability to deliver growth factors and other signaling molecules directly to hair follicles. Research suggests exosomes derived from stem cells can stimulate hair growth and improve hair quality. While still in early clinical trials, this approach holds the potential to restore hair growth in cases where traditional treatments have failed.

The FDA’s Role: Navigating Safety and Innovation

The FDA’s recent safety communication regarding compounded topical finasteride highlights the importance of regulatory oversight. As new treatments emerge, particularly in the realm of compounded medications and regenerative therapies, the FDA will play a crucial role in ensuring safety and efficacy. Expect increased scrutiny of manufacturing processes, ingredient sourcing, and clinical trial data. Consumers should prioritize treatments with a clear evidence base and avoid products with unsubstantiated claims.

The Consumer’s Evolving Expectations

Consumers are becoming more informed and demanding. They want transparency, personalization, and convenience. They’re also increasingly aware of the potential risks and side effects of hair loss treatments. This is driving a demand for more holistic approaches that address not only the physical aspects of hair loss but also the emotional and psychological impact.

The Rise of Preventative Hair Care

Beyond treating existing hair loss, there’s a growing focus on preventative hair care. Nutraceuticals containing vitamins, minerals, and antioxidants are gaining popularity, with claims of strengthening hair follicles and protecting against damage. Scalp care routines, inspired by skincare, are also becoming more common, with specialized shampoos, serums, and scalp massagers designed to promote healthy hair growth.

Frequently Asked Questions

What is the difference between FDA-approved and compounded medications? FDA-approved medications have undergone rigorous testing and review by the FDA. Compounded medications are customized formulations prepared by a licensed pharmacy, but they haven’t been FDA-approved as finished products.

Are peptides a viable alternative to traditional hair loss treatments? While some peptides show promise in preliminary research, they are not currently FDA-approved for treating hair loss. More research is needed to determine their efficacy and safety.

How effective is telehealth for hair loss treatment? Telehealth can be a convenient and accessible option for obtaining prescriptions for FDA-approved medications. However, it may not be suitable for all cases, particularly those requiring a thorough physical examination.

What should I look for in a hair loss treatment provider? Look for a provider with a strong reputation, qualified healthcare professionals, and a commitment to transparency and patient safety.

How long does it typically take to see results from hair loss treatment? Results vary depending on the treatment and individual factors. It typically takes at least 3-6 months to see noticeable improvements.

Where can I find more information about the FDA’s safety communication on compounded topical finasteride? You can find the FDA’s safety communication on their website: https://www.fda.gov/

Ready to explore your options? Share your thoughts and experiences in the comments below! Don’t forget to subscribe to our newsletter for the latest updates on hair loss treatment and preventative care.

January 9, 2026 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Foo Fighters bring their stadium show to a modest NYC venue. Inside the exclusive, surprise concert

    May 1, 2026
  • Cleveland Super Bowl: Goodell Hints at Possibility

    May 1, 2026
  • How Trinny Woodall builds her strong core at 62 – the 7-move home workout she swears by

    May 1, 2026
  • Nissan Skyline R32 meets its 2000GT-R ancestor

    May 1, 2026
  • Danish treatment of Greenlandic mother may be ‘ethnic discrimination’, says UN | Denmark

    May 1, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World